Aryl rhodanines specifically inhibit staphylococcal and enterococcal biofilm formation.
about
Recent pharmacological developments on rhodanines and 2,4-thiazolidinedionesSarA based novel therapeutic candidate against Staphylococcus aureus associated with vascular graft infectionsNew approaches for treating staphylococcal biofilm infections.Novel strategies for the prevention and treatment of biofilm related infections.Anti-biofilm agents: recent breakthrough against multi-drug resistant Staphylococcus aureus.Advances in the local and targeted delivery of anti-infective agents for management of osteomyelitis.(+)-Dehydroabietic acid, an abietane-type diterpene, inhibits Staphylococcus aureus biofilms in vitro.Norgestimate inhibits staphylococcal biofilm formation and resensitizes methicillin-resistant Staphylococcus aureus to β-lactam antibiotics.Aloe-emodin inhibits Staphylococcus aureus biofilms and extracellular protein production at the initial adhesion stage of biofilm development.Static biofilm cultures of Gram-positive pathogens grown in a microtiter format used for anti-biofilm drug discovery.Inhibition of Staphylococcus epidermidis biofilm by trimethylsilane plasma coatingaBiofilm: a resource of anti-biofilm agents and their potential implications in targeting antibiotic drug resistance.Combining biofilm matrix measurements with biomass and viability assays in susceptibility assessments of antimicrobials against Staphylococcus aureus biofilms.Control of Biofilm Formation in Healthcare: Recent Advances Exploiting Quorum-Sensing Interference Strategies and Multidrug Efflux Pump Inhibitors
P2860
Q26999467-A3E5574F-7415-462D-B987-561A51CD9A6EQ35659655-8E34DF1B-EE0E-4922-9D7E-A879FBFC3A06Q37970722-0DFDE333-C1B5-41A7-83A9-BAF79EE3738EQ38135743-51EC90F0-3CAD-401E-A79E-E3D6D7AF19CAQ38181039-52F88764-0654-41FC-8985-C67D6EB95F97Q38610253-6477E5C2-06A2-4B12-A8EB-2E6A077DF54FQ39143591-F4BC6901-8D8B-47EA-8C39-567CEE14C2A7Q40113756-6C9FA4D7-64E2-4B05-BE33-2303BE7A78DCQ40133965-0D0A5E59-F954-4EB5-8DE4-CAA9E939A924Q40851809-1A8BFB99-7ACF-44AF-8CE1-9557E0DF3455Q41569871-D9888047-47C0-404F-BB6C-0D50551C7E80Q47100874-91AF75FC-2800-423A-8733-C2AB93D414CAQ47445561-327B5C04-6A08-40B8-A32B-C2BF3B4445E0Q58753420-CEDE9325-89A6-4371-B8A7-F676C7584E4F
P2860
Aryl rhodanines specifically inhibit staphylococcal and enterococcal biofilm formation.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Aryl rhodanines specifically inhibit staphylococcal and enterococcal biofilm formation.
@ast
Aryl rhodanines specifically inhibit staphylococcal and enterococcal biofilm formation.
@en
type
label
Aryl rhodanines specifically inhibit staphylococcal and enterococcal biofilm formation.
@ast
Aryl rhodanines specifically inhibit staphylococcal and enterococcal biofilm formation.
@en
prefLabel
Aryl rhodanines specifically inhibit staphylococcal and enterococcal biofilm formation.
@ast
Aryl rhodanines specifically inhibit staphylococcal and enterococcal biofilm formation.
@en
P2093
P2860
P356
P1476
Aryl rhodanines specifically inhibit staphylococcal and enterococcal biofilm formation.
@en
P2093
Atiyya R Khan
Donald T Moir
John D Williams
Norton P Peet
Steven M Kwasny
Terry L Bowlin
Timothy J Opperman
P2860
P304
P356
10.1128/AAC.00077-09
P407
P577
2009-08-03T00:00:00Z